Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.200
-0.050 (-4.00%)
At close: Jun 12, 2026, 4:00 PM EDT
1.210
+0.010 (0.83%)
After-hours: Jun 12, 2026, 7:00 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $45.18 million as of June 12, 2026. Its market cap has decreased by -32.11% in one year.
Market Cap
45.18M
Enterprise Value
-55.80M
1-Year Change
-32.11%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $45.18M, a decrease of -91.97%. That is a compound annual growth rate of -65.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 45.18M | -25.73% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 50.20M |
| Mereo BioPharma Group | 49.77M |
| Tevogen Bio Holdings | 48.87M |
| Immutep | 48.45M |
| Xilio Therapeutics | 47.80M |
| Actuate Therapeutics | 47.61M |
| Radiopharm Theranostics | 47.10M |
| aTyr Pharma | 46.61M |